Dermatology · Beverly Hills, CA
NPI
1063494474
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8920 Wilshire Blvd, Suite 327
Beverly Hills, CA, 90211
Phone (310) 652-8460
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
377 services
Medicare patients, 2024
115
Average age 69
Drug cost, 2024
$1.4M
1,188 prescriptions
Company payments, 2025
$80K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul W Wallace was code 99214 (office e&m - established), 95 times for 54 patients. In total Paul W Wallace billed 377 services in 22 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 95 | 54 | $91.21 | $8,665 |
| 99213 Office E&M - Established | Office | 88 | 61 | $66.09 | $5,816 |
| 17110 Destruction Skin Lesion | Office | 32 | 20 | $96.23 | $3,079 |
| 99203 Office E&M - New | Office | 24 | 24 | $70.74 | $1,698 |
| 99204 Office E&M - New | Office | 22 | 22 | $112.66 | $2,479 |
By year: 2022 $20K for 367 services; 2023 $25K for 541 services; 2024 $26K for 377 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul W Wallace prescribed most often to Medicare patients was Triamcinolone Acetonide, with 190 prescriptions and refills. In total Paul W Wallace wrote 1,188 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 190 | 249 | 96 | $2,115 |
| Clobetasol Propionate Generic | 101 | 107 | 35 | $4,330 |
| Ketoconazole Generic | 99 | 103 | 36 | $1,495 |
| Zoryve Roflumilast | 73 | 77 | 24 | $66K |
| Hydrocortisone Generic | 69 | 75 | 34 | $392 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 44 | 44 | 21 | $2,334 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 41 | 41 | Under 11 | $291K |
| Clindamycin Phosphate Generic | 39 | 41 | 15 | $2,980 |
| Ciclopirox Ciclopirox Olamine | 38 | 38 | 18 | $1,477 |
| Dupixent Pen Dupilumab | 36 | 36 | Under 11 | $133K |
| Nystatin Generic | 35 | 35 | 11 | $321 |
| Tretinoin Generic | 32 | 37 | 18 | $2,653 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 30 | 31 | 16 | $481 |
| Mupirocin Generic | 28 | 28 | 19 | $105 |
| Cephalexin Generic | 26 | 26 | 24 | $279 |
Brand drugs: - claims; generic drugs: 912 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul W Wallace $80K ($80K in general payments such as food, travel and fees) from 16 companies. The largest payer was UCB, Inc. with $71K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 106 | $71K |
| Novartis Pharmaceuticals Corporation NVS | 12 | $7,827 |
| Abbvie Inc. ABBV | 3 | $198 |
| Botanix SB Inc | 3 | $179 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $127 |
| Arcutis Biotherapeutics, Inc. ARQT | 2 | $104 |
| Janssen Biotech, Inc. JNJ | 4 | $99.66 |
| Lilly USA, LLC LLY | 3 | $94.19 |
| Pfizer Inc. PFE | 5 | $65.16 |
| Amgen Inc. AMGN | 3 | $64.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.